References

1. 통계청. 2015. 2015 고령자통계.
2. 국가암정보센터. 2015. 통계로 보는 암.
3. Shih YC, Hurria A. 2014. Preparing for an epidemic: cancer care in an aging population. Am Soc Clin Oncol Educ Book 34: 133-137. https://doi.org/10.14694/EdBook_AM.2014.34.133
4. Yancik R. 2015. Population aging and cancer: a cross-national concern. Cancer J 11: 437-441.
5. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. 2008. Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials. Int J Cancer 123: 1227-1239. https://doi.org/10.1002/ijc.23754
6. Kwon Y. 2014. Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies. Food Sci Nutr 2: 613-622. https://doi.org/10.1002/fsn3.142
7. Ozben T. 2015. Antioxidant supplementation on cancer risk and during cancer therapy: an update. Curr Top Med Chem 15: 170-178. https://doi.org/10.2174/1568026615666141209160918
8. Kwon Y. 2014. Curcumin as a cancer chemotherapy sensitizing agent. J Korean Soc Appl Biol Chem 57: 273-280. https://doi.org/10.1007/s13765-014-4077-1
9. Labriola D, Livingston R. 1999. Possible interactions between dietary antioxidants and chemotherapy. Oncology 13: 1003-1008.
10. Block KI. 2004. Antioxidants and cancer therapy: furthering the debate. Integr Cancer Ther 3: 342-348. https://doi.org/10.1177/1534735404272152
11. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. 2008. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst 100: 773-783. https://doi.org/10.1093/jnci/djn148
12. Milkovic L, Siems W, Siems R, Zarkovic N. 2014. Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer. Curr Pharm Des 20: 6529-6542. https://doi.org/10.2174/1381612820666140826152822
13. Jaramillo MC, Zhang DD. 2013. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27: 2179-2191. https://doi.org/10.1101/gad.225680.113
14. Liou GY, Storz P. 2010. Reactive oxygen species in cancer. Free Radic Res 44: 479-496. https://doi.org/10.3109/10715761003667554
15. Glasauer A, Chandel NS. 2014. Targeting antioxidants for cancer therapy. Biochem Pharmacol 92: 90-101.
16. Urig S, Becker K. 2006. On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin Cancer Biol 16: 452-465. https://doi.org/10.1016/j.semcancer.2006.09.004
17. Tonissen KF, Di Trapani G. 2009. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Mol Nutr Food Res 53: 87-103. https://doi.org/10.1002/mnfr.200700492
18. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, Wong PK, Zhang DD. 2008. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29: 1235-1243. https://doi.org/10.1093/carcin/bgn095
19. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035. https://doi.org/10.1056/NEJM199404143301501
20. De Luca LM, Ross SA. 1996. Beta-carotene increases lung cancer incidence in cigarette smokers. Nutr Rev 54: 178-180.
21. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. 2014. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6: 221ra15. https://doi.org/10.1126/scitranslmed.3007653
22. Fimognari C, Lenzi M, Sciuscio D, Cantelli-Forti G, Hrelia P. 2007. Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation. Ann N Y Acad Sci 1095: 62-69. https://doi.org/10.1196/annals.1397.008
23. Sen GS, Mohanty S, Hossain DM, Bhattacharyya S, Banerjee S, Chakraborty J, Saha S, Ray P, Bhattacharjee P, Mandal D, Bhattacharya A, Chattopadhyay S, Das T, Sa G. 2011. Curcumin enhances the efficacy of chemotherapy by tailoring p65NF${\kappa}B$-p300 cross-talk in favor of p53-p300 in breast cancer. J Biol Chem 286: 42232-42247. https://doi.org/10.1074/jbc.M111.262295
24. Fang Y, DeMarco VG, Nicholl MB. 2012. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 103: 1090-1098. https://doi.org/10.1111/j.1349-7006.2012.02272.x
25. Zheng J, Lee HC, Bin Sattar MM, Huang Y, Bian JS. 2011. Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury. Eur J Pharmacol 652: 82-88. https://doi.org/10.1016/j.ejphar.2010.10.082
26. Ucuncu H, Ertekin MV, Yoruk O, Sezen O, Ozkan A, Erdogan F, Kiziltunc A, Gundogdu C. 2006. Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. J Radiat Res 47: 91-102. https://doi.org/10.1269/jrr.47.91
27. Azizi A, Alirezaei S, Pedram P, Mafi RA. 2015. Efficacy of topical and systemic vitamin E in preventing chemotherapy-induced oral mucositis. Rep Radiother Oncol 2: 15-18.
28. Kwon Y. 2016. Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Onco Targets Ther 9: 2007-2016.
29. Lin CF, Young KC, Bai CH, Yu BC, Ma CT, Chien YC, Su HC, Wang HY, Liao CS, Lai HW, Tsao CW. 2013. Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells. Immunopharmacol Immunotoxicol 35: 669-677. https://doi.org/10.3109/08923973.2013.837059
30. Ha HC, Thiagalingam A, Nelkin BD, Casero RA Jr. 2000. Reactive oxygen species are critical for the growth and differentiation of medullary thyroid carcinoma cells. Clin Cancer Res 6: 3783-3787.